These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24594337)

  • 1. Directed evolution of bicyclic peptides for therapeutic application.
    Diderich P; Heinis C
    Chimia (Aarau); 2013; 67(12-13):910-5. PubMed ID: 24594337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phage Selection of Cyclic Peptides for Application in Research and Drug Development.
    Deyle K; Kong XD; Heinis C
    Acc Chem Res; 2017 Aug; 50(8):1866-1874. PubMed ID: 28719188
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polycyclic peptide therapeutics.
    Baeriswyl V; Heinis C
    ChemMedChem; 2013 Mar; 8(3):377-84. PubMed ID: 23355488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phage selection of bicyclic peptides based on two disulfide bridges.
    Chen S; Heinis C
    Methods Mol Biol; 2015; 1248():119-37. PubMed ID: 25616330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phage selection of bicyclic peptides.
    Rentero Rebollo I; Heinis C
    Methods; 2013 Mar; 60(1):46-54. PubMed ID: 23313750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bicyclic peptide antagonists derived from genetically encoded combinatorial libraries.
    Heinis C
    Chimia (Aarau); 2011; 65(9):677-9. PubMed ID: 22026178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phage Selection of Bicyclic Peptide Ligands of the Notch1 Receptor.
    Urech-Varenne C; Radtke F; Heinis C
    ChemMedChem; 2015 Oct; 10(10):1754-61. PubMed ID: 26381087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclic peptide therapeutics: past, present and future.
    Zorzi A; Deyle K; Heinis C
    Curr Opin Chem Biol; 2017 Jun; 38():24-29. PubMed ID: 28249193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA display selection and solid-phase synthesis of Fc-binding cyclic peptide affinity ligands.
    Menegatti S; Hussain M; Naik AD; Carbonell RG; Rao BM
    Biotechnol Bioeng; 2013 Mar; 110(3):857-70. PubMed ID: 23108907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclic peptides as potential therapeutic agents for skin disorders.
    Namjoshi S; Benson HA
    Biopolymers; 2010; 94(5):673-80. PubMed ID: 20564043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structurally diverse cyclisation linkers impose different backbone conformations in bicyclic peptides.
    Chen S; Morales-Sanfrutos J; Angelini A; Cutting B; Heinis C
    Chembiochem; 2012 May; 13(7):1032-8. PubMed ID: 22492661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Affinity-Selected Bicyclic Peptide G-Quadruplex Ligands Mimic a Protein-like Binding Mechanism.
    Liu KC; Röder K; Mayer C; Adhikari S; Wales DJ; Balasubramanian S
    J Am Chem Soc; 2020 May; 142(18):8367-8373. PubMed ID: 32267689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bicyclic Peptides as Next-Generation Therapeutics.
    Rhodes CA; Pei D
    Chemistry; 2017 Sep; 23(52):12690-12703. PubMed ID: 28590540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design and evaluation of a 6-mer amyloid-beta protein derived phage display library for molecular targeting of amyloid plaques in Alzheimer's disease: Comparison with two cyclic heptapeptides derived from a randomized phage display library.
    Larbanoix L; Burtea C; Ansciaux E; Laurent S; Mahieu I; Vander Elst L; Muller RN
    Peptides; 2011 Jun; 32(6):1232-43. PubMed ID: 21575663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel genetically-encoded bicyclic peptide inhibitor of human urokinase-type plasminogen activator with better cross-reactivity toward the murine orthologue.
    Mazzocato Y; Perin S; Morales-Sanfrutos J; Romanyuk Z; Pluda S; Acquasaliente L; Borsato G; De Filippis V; Scarso A; Angelini A
    Bioorg Med Chem; 2023 Nov; 95():117499. PubMed ID: 37879145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phage selection of cyclic peptide antagonists with increased stability toward intestinal proteases.
    Baeriswyl V; Heinis C
    Protein Eng Des Sel; 2013 Jan; 26(1):81-9. PubMed ID: 23100545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro selection of unnatural cyclic peptide libraries via mRNA display.
    Ma Z; Hartman MC
    Methods Mol Biol; 2012; 805():367-90. PubMed ID: 22094817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. De novo discovery of bioactive cyclic peptides using bacterial display and flow cytometry.
    Shivange AV; Daugherty PS
    Methods Mol Biol; 2015; 1248():139-53. PubMed ID: 25616331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly selective cyclic peptide ligands for NeutrAvidin and avidin identified by phage display.
    Meyer SC; Gaj T; Ghosh I
    Chem Biol Drug Des; 2006 Jul; 68(1):3-10. PubMed ID: 16923020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phage-encoded combinatorial chemical libraries based on bicyclic peptides.
    Heinis C; Rutherford T; Freund S; Winter G
    Nat Chem Biol; 2009 Jul; 5(7):502-7. PubMed ID: 19483697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.